|
|
|
|
Дата |
|---|
| 23.02.2026 |
| 22.02.2026 |
| 19.02.2026 |
| 18.02.2026 |
| 17.02.2026 |
| 16.02.2026 |
| 15.02.2026 |
| 12.02.2026 |
| 11.02.2026 |
| 10.02.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
62.38
|
62.00
|
63.73
|
63.21
|
|
|
888 419.24
|
110.00
|
|
|
|
64.04
|
62.05
|
64.94
|
62.38
|
|
|
1 634 133.55
|
143.00
|
|
|
|
64.84
|
63.70
|
65.49
|
64.04
|
|
|
2 215 915.14
|
166.00
|
|
|
|
65.03
|
64.72
|
65.67
|
64.84
|
|
|
1 190 723.85
|
149.00
|
|
|
|
64.53
|
64.55
|
65.96
|
65.03
|
|
|
2 561 406.69
|
223.00
|
|
|
|
66.09
|
64.50
|
66.88
|
64.53
|
|
|
2 721 741.08
|
244.00
|
|
|
|
66.17
|
65.71
|
66.98
|
66.09
|
|
|
3 241 113.14
|
261.00
|
|
|
|
67.43
|
65.60
|
67.40
|
66.17
|
|
|
2 269 973.68
|
239.00
|
|
|
|
66.36
|
66.51
|
68.38
|
67.43
|
|
|
966 371.42
|
147.00
|
|
|
|
68.31
|
65.01
|
68.89
|
66.36
|
|
|
2 099 322.20
|
209.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
08.01.2026
|
11.01.2026 |
1 EGP |
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
